関連論文
-
Associations between changes in social contact pattern and the mental health status of Chinese adults: cross-sectional findings
-
Study profile of The Tohoku Medical Megabank Community-Based Cohort Study.
-
Chemogenetic activation of the mPFC alleviates impaired fear memory extinction in an animal model of PTSD
-
Chemogenetic activation of the mPFC alleviates impaired fear memory extinction in an animal model of PTSD
-
Study on the effect of S-allyl cysteine on testosterone production and neuroprotection
参考文献
1)
2)
3)
4)
5)
6)
American Psychiatric Association : Obsessive-Compulsive and Related Disorders. Diagnostic and Statistical
Manual of Mental Disorders, Fifth Edition : DSM-5. American Psychiatric Publishing, Washington, DC, pp.
235-264, 2013.
日本うつ病学会・気分障害の治療ガイドライン作成委員会:日本うつ病学会治療ガイドラインⅡ.うつ病
(DSM-5)/大うつ病性障害, 日本うつ病学会, 2016.
Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M and Möller HJ : World Federation of
Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive
Disorders in Primary Care. World. J. Biol. Psychiatry. 8 : 67-104, 2007.
National Collaborating Centre for Mental Health (UK) : National Institute for Health and Clinical Excellence
(NICE). Depression in adults : The treatment and management of depression in adults. National Collaborating
Centre for Mental Health, UK, 2007.
渡邊衡一郎:精神科外来臨床における非薬物療法的アプローチの位置づけと期待―うつ病を例に― 総合病
院精神医学 25:262-267,2013.
Jacobson NS, Martell CR and Dimidjian S : Behavioral activation treatment for depression : returning to
contextual roots. Clin Psychol : Science and technology, 8 : 255-270, 2001.
うつ病・不安症の理解と治療
7)
8)
9)
10)
11)
12)
21
中尾智博:うつ病の行動活性化療法―理論と実践―.特集 うつ病治療における行動活性化―「休息と薬物
療法」を超えていかに導入するか―.精神神経誌 117:18-25,2015.
Martell CR and Addis ME:うつを克服するための行動活性化練習帳 ―認知行動療法の新しい技法.大野裕,
岡本泰昌,創元社,2012.
Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ ; WFSBP Task Force on Treatment Guidelines for
Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disoders, Zohar J, Hollander E, Kasper S, Möller
HJ, Bandelow B, Allgulander C, Ayuso-Gutierrez J, Baldwin DS, Buenvicius R, Cassano G, Fineberg N,
Gabriels L, Hindmarch I, Kaiya H, Klein DF, Lader M, Lecrubier Y, Lépine JP, Liebowitz MR, Lopez-Ibor JJ,
Marazziti D, Miguel EC, Oh KS, Preter M, Rupprecht R, Sato M, Starcevic V, Stein DJ, van Ameringen M and
Vega J : World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological
Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders First Revision. World J
Biol Psychiatry. 9 : 248-312, 2008.
Skapinakis P, Caldwell DM, Hollingworth W, Bryden P, Fineberg NA, Salkovskis P, Welton NJ, Baxter H,
Kessler D, Churchill R and Lewis G : Pharmacological and psychotherapeutic interventions for management of
obsessive-compulsive disorder in adults : a systematic review and network meta-analysis. Lancet Psychiatry.
3 : 730-739, 2016.
Zhou DD, Zhou XX, Lv Z, Chen XR, Wang W, Wang GM, Liu C, Li DQ and Kuang L : Comparative efficacy and
tolerability of antipsychotics as augmentations in adults with treatment-resistant obsessive-compulsive
disorder : A network meta-analysis. J Psychiatr Res. 111 : 51-58, 2019.
中尾智博:強迫性障害における認知行動療法活用術.疾患・領域別最新認知行動療法活用術.精神療法増刊
第 7 号,73-83,2020.
(特に重要な文献については,番号をゴシック体で表記している.
著者プロフィール
中尾 智博(なかお ともひろ)
九州大学教授(大学院医学研究院精神病態医学分野).医学博士.
◆略歴 1970 年鹿児島県に生まれる.1995 年九州大学医学部卒業.同年精神病態医学教室に入局.
2005 年同大学院医学系研究科博士課程修了.2006 年九州大学医学部助教.2010〜2011 年
ロンドン大学客員研究員.2011 年九州大学医学部講師.2017 年同診療准教授併任.2020
年より現職(第 8 代目教授).
◆研究テーマと抱負 不安症・強迫症の臨床と研究.認知行動療法の実践.我々の教室では臨床精
神医学の実践とともに基礎から臨床に至る幅広い領域の研究を行っている.先代神庭重信
名誉教授の思想を引き継ぎ,教室員の個性と多様性を大事にしながらさらなる発展を目指
したい.
◆趣味 ドライブ,読書,ワイン.
22
Understanding and Treatment of Depression and Anxiety Disorders
Tomohiro NAKAO
Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University
Abstract
Recently, the number of patients with depression and anxiety disorders is steadily increasing under
the stressful modern society. Further increase of these disorders are worried due to the COVID-19.
Though the first lines of pharmacotherapy for these disorders are new generation antidepressants
including SSRI and SNRI, not a few patient response inadequately. On the other hand, regarding
psychotherapy, there are numerous evidences of the effectiveness of cognitive behavior therapy
(CBT). In most treatment guidelines, CBT are recommended as a first line treatment, as well as
pharmacotherapy with SSRI/SNRIs. In this review, I will provide comprehensive commentaries of
treatment strategies including CBT on depression, social anxiety disorder and obsessive-compulsive
disorder.
Key words : depression, anxiety disorder, obsessive-compulsive disorder (OCD), cognitive behavior
therapy (CBT), behavioral activation (BA)
...